CAFs, in particular, are vital contributors to ECM remodeling, secreting collagen I and fibronectin that increase ECM stiffness and activate tumor-promoting signaling pathways, including the YAP/TAZ pathway. The gene discussed is FN1; the disease is neoplasm.